| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf0b2517d794e4715d29bfcb609ce7cf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1741 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755 |
| filingDate |
2016-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ad2a75c98e1911c0b2c548cdeb7537d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f1000538c91c27e502d2a7a68e942cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f6ceb28d0f7323696ea55de391ef13a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f2f8895958040dbb40713fba64755a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c99c2ff6a4f0cfda0ea960e30fbb35b |
| publicationDate |
2018-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180012303-A |
| titleOfInvention |
Method for producing modified von Willebrand factor |
| abstract |
The present invention provides modified von Willebrand factor molecules, methods for their preparation and uses thereof. The present invention further provides a pharmaceutical composition for the treatment of clotting disorders. |
| priorityDate |
2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |